• 1. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 4. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 5. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804

• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds C-nitro compounds
• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds Organic nitro compounds C-nitro compounds

3-Pyridinecarbonitrile, 2-methyl-5-nitro-: A Comprehensive Overview

3-Pyridinecarbonitrile, 2-methyl-5-nitro- is a specialized chemical compound that has garnered significant attention in the field of biomedical research due to its unique structural properties and potential applications. This compound belongs to the class of pyridine derivatives, characterized by the presence of a pyridine ring with specific substituents, including a cyano group (-CN) at position 3, a methyl group (-CH?) at position 2, and a nitro group (-NO?) at position 5. These functional groups endow the compound with distinct chemical reactivity and biological activity, making it a subject of interest in drug discovery, antibacterial research, and tumor-targeting therapies.

The cyano group in 3-Pyridinecarbonitrile, 2-methyl-5-nitro- imparts strong electron-withdrawing properties, which can influence the compound's reactivity and stability. The nitro group, being another electron-withdrawing substituent, further enhances these characteristics, potentially modulating the compound's interactions with biological systems. The methyl group at position 2 serves to slightly alter the electronic environment of the pyridine ring, introducing steric effects that may influence binding affinities in molecular interactions.

Recent studies have explored the potential of 3-Pyridinecarbonitrile, 2-methyl-5-nitro- as a lead compound in anticancer drug development. Its structural features, particularly the pyridine ring and the presence of electron-withdrawing groups, make it a promising candidate for designing molecules that can target specific pathways involved in cancer progression. For instance, research has demonstrated that this compound exhibits anticancer activity through mechanisms such as cell cycle modulation, apoptosis induction, and anti-angiogenesis effects.

In addition to its role in oncology, 3-Pyridinecarbonitrile, 2-methyl-5-nitro- has shown promising results in antibacterial research. The compound's ability to disrupt bacterial cell walls and interfere with essential metabolic pathways positions it as a potential candidate for developing novel antibiotics. This is particularly relevant in the context of rising antibiotic resistance, where new compounds are urgently needed to combat multidrug-resistant pathogens.

The synthesis of 3-Pyridinecarbonitrile, 2-methyl-5-nitro- involves a series of well-established organic chemistry techniques. The introduction of substituents at specific positions on the pyridine ring requires careful control over reaction conditions to ensure regioselectivity and yield. Researchers have optimized synthetic routes to enhance efficiency and scalability, enabling the compound's broader use in biomedical applications.

Another area of interest lies in the toxicological evaluation of 3-Pyridinecarbonitrile, 2-methyl-5-nitro-. Understanding its safety profile is crucial for its development as a therapeutic agent. Preclinical studies have focused on assessing the compound's toxicity, pharmacokinetics, and biocompatibility, providing valuable insights into its suitability for further clinical testing.

Recent advancements in nanotechnology have also opened new avenues for leveraging 3-Pyridinecarbonitrile, 2-methyl-5-nitro- as a component of drug delivery systems. The compound's physicochemical properties make it a candidate for incorporation into nanoparticles or liposomes, enhancing its bioavailability and targeting efficiency in specific tissues or cells.

Moreover, the study of 3-Pyridinecarbonitrile, 2-methyl-5-nitro- has contributed to a deeper understanding of pyridine-based drugs. Its structure serves as a model for exploring the relationship between chemical structure and biological activity, guiding the design of more effective and selective agents in various therapeutic areas.

In conclusion, 3-Pyridinecarbonitrile, 2-methyl-5-nitro- represents a valuable tool in the arsenal of biomedical research. Its unique combination of functional groups positions it at the forefront of innovation in anticancer, antibacterial, and nanomedicine applications. As research continues to unravel its full potential, this compound is poised to play a significant role in addressing some of the most pressing challenges in modern medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)